A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Part of paid clinical trials in Fullerton, California.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT06976203
- Phase
- PHASE3
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- KarXT — DRUGSpecified dose on specified days
- KarX-EC — DRUGSpecified dose on specified days
- Placebo — OTHERSpecified dose on specified days
Study Details
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease
Key Dates
- Start date
- Jul 21, 2025
- Status verified
- Jun 2026
- Primary completion
- Sep 11, 2028
- Completion
- Feb 23, 2029
Study Design
- Enrollment
- 586 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: KarXT + KarX-EC
- Placebo Comparator: Placebo
Primary Outcome Measure
Change from baseline in Alzheimer's Disease Assessment Scale-Cognitive Subscale 11 (ADAS-Cog11) [ Time Frame: At week 24 ]
Central Contacts
- BMS Clinical Trials Contact Center www.BMSClinicalTrials.com855-907-3286
- First line of the email MUST contain NCT # and Site #.
Locations (30)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Fullerton Neurology and Headache Center | Fullerton | California | 92835 | Jack Florin, Site 0072 714-381-0801 |
| Inglewood Clinical | Inglewood | California | 90301 | Edward Zamrini, Site 0091 706-863-9595 |
| Irvine Clinical Research | Irvine | California | 92614 | Elly Lee, Site 0095 949-753-1663 |
| Local Institution - 0083 | Palo Alto | California | 94304 | Site 0083 |
| Local Institution - 0069 | San Diego | California | 92103 | - |
| Research of the Rockies | Colorado Springs | Colorado | 80919 | Adam Wolff, Site 0088 303-715-9024 |
| Neuropsychiatric Research Center of Southwest Florida | Fort Myers | Florida | 33912 | Jennifer Springer, Site 0090 239-939-7777 |
| Local Institution - 0086 | Hallandale | Florida | 33009 | - |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | Steven Toenjes, Site 0092 904-673-1252 |
| K2 MEDICAL Research THE VILLAGES | Lady Lake | Florida | 32159 | Craig Curtis, Site 0114 407-426-9299 |
| Intercoastal Medical Group | Sarasota | Florida | 34239 | Mauricio Concha, Site 0082 941-203-3750 |
| USF Health Byrd Alzheimer's Institute | Tampa | Florida | 33613 | Amanda Smith, Site 0084 813-974-4355 |
| Alzheimer's Research and Treatment Center | Wellington | Florida | 33414 | David Watson, Site 0089 561-209-2400 |
| Great Lakes Clinical Trials - Andersonville | Chicago | Illinois | 60640 | Jeffrey Ross, Site 0093 847-252-7300 |
| Southern Illinois University School of Medicine | Springfield | Illinois | 62702 | Jennifer Arnold, Site 0070 217-545-7197 |
| Josephson Wallack Munshower Neurology, PC | Indianapolis | Indiana | 46256 | Kristi George, Site 0071 317-537-6088 |
| Local Institution - 0080 | Watertown | Massachusetts | 02472 | Site 0080 |
| QUEST Research Institute | Farmington Hills | Michigan | 48334 | Aaron Ellenbogen, Site 0073 248-957-8940 |
| Private Practice - Dr. Ronald Louis Schwartz | Hattiesburg | Mississippi | 39401 | Ronald Schwartz, Site 0085 601-606-0911 |
| Local Institution - 0119 | Ridgewood | New Jersey | 07450 | - |
| The Cognitive and Research Center of New Jersey | Springfield | New Jersey | 07081 | Raminder Parihar, Site 0094 973-850-4622 |
| Advanced Clinical Institute | West Long Branch | New Jersey | 07764 | Mark Ornstein, Site 0075 732-807-4700 |
| Neurological Associates Albany | Albany | New York | 12208 | Richard Holub, Site 0077 518-426-0575 |
| Dent Neurosciences Research Center, Inc | Amherst | New York | 14226 | Horacio Capote, Site 0068 716-250-2000 |
| University at Buffalo - UBMD Neurology | Buffalo | New York | 14203 | Kinga Szigeti, Site 0087 281-630-2316 |
| Local Institution - 0078 | Lake Success | New York | 11042 | - |
| Keystone Clinical Studies | Plymouth Meeting | Pennsylvania | 19462 | Cameron Olezene, Site 0105 610-277-8073 |
| Local Institution - 0081 | Dallas | Texas | 75231 | Site 0081 |
| Central Texas Neurology Consultants, PA | Round Rock | Texas | 78681 | Elizabeth Peckham, Site 0079 443-852-2085 |
| Rainier Clinical Research Center | Renton | Washington | 98057 | Sheryl Marks, Site 0076 425-251-1722 |
Find similar trials in Fullerton, CA
By condition
By specialty
Related Studies
- Dominantly Inherited Alzheimer Network (DIAN)Recruiting · Washington University School of Medicine · Jacksonville, Florida
- PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric DiseasesPHASE1/PHASE2 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
- A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive ImpairmentPHASE1 · Recruiting · Mark Tuszynski · La Jolla, California
- A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)PHASE1/PHASE2 · Recruiting · AC Immune SA · Phoenix, Arizona